Advertisement
Canada markets open in 1 hour 38 minutes
  • S&P/TSX

    24,561.20
    +122.12 (+0.50%)
     
  • S&P 500

    5,842.47
    +27.21 (+0.47%)
     
  • DOW

    43,077.70
    +337.28 (+0.79%)
     
  • CAD/USD

    0.7259
    -0.0013 (-0.18%)
     
  • CRUDE OIL

    70.42
    +0.03 (+0.04%)
     
  • Bitcoin CAD

    92,035.52
    -1,917.83 (-2.04%)
     
  • XRP CAD

    0.76
    +0.01 (+1.27%)
     
  • GOLD FUTURES

    2,701.40
    +10.10 (+0.38%)
     
  • RUSSELL 2000

    2,286.68
    +36.86 (+1.64%)
     
  • 10-Yr Bond

    4.0160
    -0.0220 (-0.54%)
     
  • NASDAQ futures

    20,513.50
    +164.00 (+0.81%)
     
  • VOLATILITY

    19.35
    -0.23 (-1.17%)
     
  • FTSE

    8,363.20
    +34.13 (+0.41%)
     
  • NIKKEI 225

    38,911.19
    -269.11 (-0.69%)
     
  • CAD/EUR

    0.6677
    -0.0014 (-0.21%)
     

Why Teradyne (TER) Shares Are Falling Today

TER Cover Image
Why Teradyne (TER) Shares Are Falling Today

What Happened:

Shares of semiconductor testing company Teradyne (NASDAQ:TER) fell 15.3% in the afternoon session after the company reported second-quarter earnings results. Its revenue guidance for next quarter missed analysts' expectations. On the other hand, Teradyne recorded strong improvement in inventory levels, and its EPS outperformed Wall Street's estimates. The guidance seems to be weighing on shares, and the stock traded down as a result.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Teradyne? Access our full analysis report here, it's free.

What is the market telling us:

Teradyne's shares are quite volatile and over the last year have had 8 moves greater than 5%. But moves this big are very rare even for Teradyne and that is indicating to us that this news had a significant impact on the market's perception of the business.

The biggest move we wrote about over the last year was 6 months ago, when the stock dropped 10% on the news that the company reported fourth-quarter results, with revenue coming in below Wall Street's expectations. Also, the company's revenue and EPS guidance for next quarter both missed analysts' expectations by a large amount. Management explained this, saying, "Looking into the new year (2024), we expect low tester utilization will impact demand in the first half of the year." Though, demand is expected to pick up incrementally in the rest of the year. Overall, this was a mixed quarter for Teradyne, with guidance that was particularly bad.

Teradyne is up 18.6% since the beginning of the year, but at $124.30 per share it is still trading 23.7% below its 52-week high of $163 from July 2024. Investors who bought $1,000 worth of Teradyne's shares 5 years ago would now be looking at an investment worth $2,224.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.